TCNNF
Price
$5.73
Change
+$0.30 (+5.52%)
Updated
Aug 8 closing price
Capitalization
1.1B
86 days until earnings call
TKPHF
Price
$28.56
Change
+$1.06 (+3.85%)
Updated
Aug 7 closing price
Capitalization
45.86B
Interact to see
Advertisement

TCNNF vs TKPHF

Header iconTCNNF vs TKPHF Comparison
Open Charts TCNNF vs TKPHFBanner chart's image
Trulieve Cannabis
Price$5.73
Change+$0.30 (+5.52%)
Volume$715.43K
Capitalization1.1B
Takeda Pharmaceutical
Price$28.56
Change+$1.06 (+3.85%)
Volume$250.1K
Capitalization45.86B
TCNNF vs TKPHF Comparison Chart in %
Loading...
TCNNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TCNNF vs. TKPHF commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TCNNF is a Hold and TKPHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (TCNNF: $5.73 vs. TKPHF: $28.56)
Brand notoriety: TCNNF and TKPHF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: TCNNF: 160% vs. TKPHF: 140%
Market capitalization -- TCNNF: $1.5B vs. TKPHF: $45.62B
TCNNF [@Pharmaceuticals: Generic] is valued at $1.5B. TKPHF’s [@Pharmaceuticals: Generic] market capitalization is $45.62B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $66.04B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TCNNF’s FA Score shows that 1 FA rating(s) are green whileTKPHF’s FA Score has 1 green FA rating(s).

  • TCNNF’s FA Score: 1 green, 4 red.
  • TKPHF’s FA Score: 1 green, 4 red.
According to our system of comparison, TKPHF is a better buy in the long-term than TCNNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TCNNF’s TA Score shows that 5 TA indicator(s) are bullish while TKPHF’s TA Score has 6 bullish TA indicator(s).

  • TCNNF’s TA Score: 5 bullish, 4 bearish.
  • TKPHF’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TCNNF is a better buy in the short-term than TKPHF.

Price Growth

TCNNF (@Pharmaceuticals: Generic) experienced а +21.91% price change this week, while TKPHF (@Pharmaceuticals: Generic) price change was +3.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.48%. For the same industry, the average monthly price growth was +8.38%, and the average quarterly price growth was +79.14%.

Reported Earning Dates

TCNNF is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.48% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TKPHF($45.9B) has a higher market cap than TCNNF($1.1B). TCNNF YTD gains are higher at: 10.543 vs. TKPHF (6.776). TKPHF has higher annual earnings (EBITDA): 1.13T vs. TCNNF (275M). TKPHF has more cash in the bank: 419B vs. TCNNF (328M). TCNNF has less debt than TKPHF: TCNNF (824M) vs TKPHF (4.51T). TKPHF has higher revenues than TCNNF: TKPHF (4.48T) vs TCNNF (1.19B).
TCNNFTKPHFTCNNF / TKPHF
Capitalization1.1B45.9B2%
EBITDA275M1.13T0%
Gain YTD10.5436.776156%
P/E RatioN/A49.17-
Revenue1.19B4.48T0%
Total Cash328M419B0%
Total Debt824M4.51T0%
FUNDAMENTALS RATINGS
TCNNF vs TKPHF: Fundamental Ratings
TCNNF
TKPHF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9489
PRICE GROWTH RATING
1..100
4259
P/E GROWTH RATING
1..100
1737
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TKPHF's Valuation (5) in the null industry is significantly better than the same rating for TCNNF (84). This means that TKPHF’s stock grew significantly faster than TCNNF’s over the last 12 months.

TKPHF's Profit vs Risk Rating (100) in the null industry is in the same range as TCNNF (100). This means that TKPHF’s stock grew similarly to TCNNF’s over the last 12 months.

TKPHF's SMR Rating (89) in the null industry is in the same range as TCNNF (94). This means that TKPHF’s stock grew similarly to TCNNF’s over the last 12 months.

TCNNF's Price Growth Rating (42) in the null industry is in the same range as TKPHF (59). This means that TCNNF’s stock grew similarly to TKPHF’s over the last 12 months.

TCNNF's P/E Growth Rating (17) in the null industry is in the same range as TKPHF (37). This means that TCNNF’s stock grew similarly to TKPHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TCNNFTKPHF
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
47%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
62%
Momentum
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
42%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
42%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
46%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
46%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 12 days ago
39%
Declines
ODDS (%)
Bearish Trend 27 days ago
87%
Bearish Trend 15 days ago
42%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 5 days ago
61%
Aroon
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
43%
View a ticker or compare two or three
Interact to see
Advertisement
TCNNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIDAX18.730.18
+0.97%
JHancock Financial Industries A
TRIHX74.450.63
+0.85%
Nuveen Large Cap Gr Idx I
ADOIX19.080.12
+0.63%
Axs Dynamic Opportunity I
EAALX22.240.11
+0.50%
Eaton Vance Atlanta Capital Focused Gr A
JIJRX15.20-0.02
-0.13%
JHancock International Dynamic Gr R6

TCNNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCNNF has been closely correlated with GTBIF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCNNF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCNNF
1D Price
Change %
TCNNF100%
+5.52%
GTBIF - TCNNF
82%
Closely correlated
+2.15%
CURLF - TCNNF
78%
Closely correlated
+13.97%
VRNOF - TCNNF
76%
Closely correlated
+12.95%
CRLBF - TCNNF
76%
Closely correlated
+9.79%
TSNDF - TCNNF
75%
Closely correlated
+8.76%
More

TKPHF and

Correlation & Price change

A.I.dvisor tells us that TKPHF and TCNNF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKPHF and TCNNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKPHF
1D Price
Change %
TKPHF100%
N/A
TCNNF - TKPHF
14%
Poorly correlated
+5.52%
VTRS - TKPHF
11%
Poorly correlated
+3.30%
SGIOY - TKPHF
9%
Poorly correlated
+1.11%
SFOSF - TKPHF
7%
Poorly correlated
N/A
RSCI - TKPHF
2%
Poorly correlated
N/A
More